Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS

Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients

Deliverables

Report on Ethics Monitoring Strategy

D71 Report on Ethics Monitoring Strategy Month 3

Communication and Outreach plan

Communication and Outreach plan Month 6

DLNN algorithms (freely available via GitHub) (Task 4)

D62 DLNN algorithms freely available via GitHub Task 4 Month 15

DLNN algorithms (freely available via GitHub) (Task 1)

D6.1: DLNN algorithms (freely available via GitHub) (Task 1) (Month 6)

Project brochure and professional templates

Project brochure and professional templates Month 6

Go-online of the public project website (Month 04)

Goonline of the public project website Month 04

Go-online of the public project website

Goonline of the public project website Month 4

Publications

Predicting childhood and adolescent attention-deficit/hyperactivity disorder onset: a nationwide deep learning approach

Author(s): Miguel Garcia-Argibay, Yanli Zhang-James, Samuele Cortese, Paul Lichtenstein, Henrik Larsson & Stephen V. Faraone
Published in: Molecular Psychiatry, Issue 28, 2022, Page(s) 1232–1239, ISSN 1476-5578
Publisher: Springer Nature
DOI: 10.1038/s41380-022-01918-8

Cardiovascular risk factors in attention-deficit/hyperactivity disorder: A family design study of Swedish conscripts

Author(s): Larsson H, Garcia-Argibay M, Du Rietz E, Hartman CA, Lichtenstein P, Chang Z, Fava C, Cortese S
Published in: International Journal of Methods in Psychiatric Research, Issue 10498931, 2022, ISSN 1049-8931
Publisher: Whurr Publishers Ltd.
DOI: 10.1002/mpr.1930

The role of ADHD genetic risk in mid-to-late life somatic health conditions

Author(s): Brikell I, Garcia-Argibay M, du Rietz E, Lu Y, Martin J, Haan E, Lehto K, Bergen SE, Lichtenstein P, Larsson H
Published in: Translational Psychiatry, Issue 21583188, 2022, ISSN 2158-3188
Publisher: Nature Publishing Group
DOI: 10.1038/s41398-022-01933-x

Association of ADHD symptoms with type 2 diabetes and cardiovascular comorbidities in adults receiving outpatient diabetes care.

Author(s): A. Z. Dehnavi, Y. Zhang-James, D. Draytsel, B. Carguello, S.V. Faraone and R. S. Weinstock
Published in: Journal of Clinical & Translational Endocrinology, Issue 32, 2023, ISSN 2214-6237
Publisher: Elsevier
DOI: 10.1016/j.jcte.2023.100318

Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis

Author(s): Bruno C, Zoega H, Gillies MB, et al.
Published in: The Australian and New Zealand Journal of Psychiatry, Issue 57(7):1073-1076, 2023, ISSN 1440-1614
Publisher: Australian and New Zealand journal of psychiatry
DOI: 10.1177/00048674231170556

Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: Evidence From Multiple Genetically Informed Designs

Author(s): Garcia Argibay, M., Isabell Brikell, Anita Thapar, Paul Lichtenstein, Sebastian Lundström, Ditte Demontis, Henrik Larsson
Published in: Biological Psychiatry, Issue Volume 95, ISSUE 5, 2023, Page(s) P444-452, ISSN 1873-2402
Publisher: Biological Psychiatry
DOI: 10.1016/j.biopsych.2023.07.017

The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study

Author(s): Miguel Garcia-Argibay, Lin Li, Ebba Du Rietz, Le Zhang, Honghui Yao, Johan Jendle, Josep A. Ramos-Quiroga, Marta Ribasés, Zheng Chang, Isabell Brikell, Samuele Cortese, Henrik Larsson
Published in: Neuroscience & Biobehavioral Reviews, Issue Volume 147, 105076, 2023, ISSN 0149-7634
Publisher: Pergamon Press Ltd.
DOI: 10.1016/j.neubiorev.2023.105076

Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study

Author(s): Larsson H, Li L, Chang Z, Sun J, Garcia-Argibay M, Du Rietz E, Dobrosavljevic M, Brikell I, Jernberg T, Solmi M, Cortese S
Published in: World Psychiatry, Issue 17238617, 2022, Page(s) 452-459, ISSN 1723-8617
Publisher: Masson Italia Periodici
DOI: 10.1002/wps.21020

ADHD Remote Technology study of cardiometabolic risk factors and medication adherence (ART-CARMA): a multi-centre prospective cohort study protocol

Author(s): Denyer H, Ramos-Quiroga JA, Folarin A, Ramos C, Nemeth P, Bilbow A, Woodward E, Whitwell S, Müller-Sedgwick U, Larsson H, Dobson RJB, Kuntsi J.
Published in: BMC Psychiatry, Issue 22, 2022, Page(s) 813, ISSN 1471-244X
Publisher: BioMed Central
DOI: 10.1186/s12888-022-04429-6

Methylphenidate and Short-Term Cardiovascular Risk

Author(s): Miguel Garcia-Argibay, Paul-Christian Bürkner, Paul Lichtenstein, Le Zhang, Brian M. D’Onofrio, Pontus Andell, Zheng Chang, Samuele Cortese, Henrik Larsson
Published in: JAMA Network Open, Issue 2024;7(3):e241349, 2024, ISSN 2574-3805
Publisher: Jama Network Open
DOI: 10.1001/jamanetworkopen.2024.1349

Association Between ADHD and COVID-19 Infection and Clinical Outcomes: A Retrospective Cohort Study From Electronic Medical Records

Author(s): Kathaleen Heslin, Aminat Haruna, Regina A George, Shiyu Chen, Ishak Nobel, Kathryn B Anderson, Stephen V Faraone and Yanli Zhang-James
Published in: Journal of Attention Disorders, 2022, ISSN 1087-0547
Publisher: SAGE Publications
DOI: 10.1177/10870547221129305

Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: A systematic review and meta-analysis

Author(s): Zheng Chang, Le Zhang, Honghui Yao, Lin Li, Ebba Du Rietz, Pontus Andell, Miguel Garcia-Argibay, Brian M. D’Onofrio, Samuele Cortese, Henrik Larsson
Published in: JAMA Network Open / Psychiatry, 2022, ISSN 2168-622X
Publisher: American Medical Association
DOI: 10.1001/jamanetworkopen.2022.43597

Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals

Author(s): Zhou, H., Kember, R.L., Deak, J.D. et al.
Published in: Nature Medicine, Issue 29, 3184–3192, 2023, ISSN 1078-8956
Publisher: Nature Publishing Group
DOI: 10.1038/s41591-023-02653-5

Association between Attention Deficit Hyperactivity Disorder and outcomes after metabolic and bariatric surgery: a nationwide propensity matched cohort study

Author(s): Erik Stenberg, Henrik Larsson, Richard Marsk, Yang Cao, Magnus Sundbom, Erik Näslund
Published in: Surgery for Obesity and Related Diseases, Issue 15507289, 2022, ISSN 1550-7289
Publisher: Elsevier BV
DOI: 10.1016/j.soard.2022.10.028

Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder

Author(s): Maja Dobrosavljevic; Seena Fazel; Ebba Du Rietz; Lin Li; Le Zhang; Zheng Chang; Tomas Jernberg; Stephen V Faraone; Johan Jendle; Qi Chen; Isabell Brikell; Henrik Larsson
Published in: Evid Based Ment Health, Issue 13620347, 2022, ISSN 1362-0347
Publisher: BMJ Publishing Group
DOI: 10.1136/ebmental-2022-300492

Genetic Architecture of ADHD and Overlap With Other Psychiatric Disorders And Cognition-Related Phenotypes.

Author(s): Ribasés, M., Mitjans, M., Hartman, C. A., Soler Artigas, M., Demontis, D., Larsson, H., Ramos-Quiroga, J. A., Kuntsi, J., Faraone, S. V., Børglum, A. D., Reif, A., Franke, B., & Cormand, B.
Published in: Neuroscience and Biobehavioral Reviews, Issue 153, Article 105313, 2023, ISSN 1873-7528
Publisher: Elsevier
DOI: 10.1016/j.neubiorev.2023.105313

Rare coding variants in ten genes confer substantial risk for schizophrenia.

Author(s): M.J. Daly, Singh, T., T. Poterba, D. Curtis, H. Akil, M. Al Eissa, J. D. Barchas, N. Bass, T. B. Bigdeli, G. Breen, E. J. Bromet, P. F. Buckley, W. E. Bunney, J. Bybjerg-Grauholm, W. F. Byerley, S. B. Chapman, W. J. Chen, C. Churchhouse, N. Craddock, C. M. Cusick, L. DeLisi, S. Dodge, M. A. Escamilla, S. Eskelinen, A. H. Fanous, S.V. Faraone, A. Fiorentino, L. Francioli, S. B. Gabriel, D. Gage, S.
Published in: Nature, Issue 00280836, 2022, Page(s) 509–516, ISSN 0028-0836
Publisher: Nature Publishing Group
DOI: 10.1038/s41586-022-04556-w

"Polygenic resilience scores capture protective genetic effects for Alzheimer's disease."""

Author(s): Hou, J., J. L. Hess, N. Armstrong, J. C. Bis, B. Grenier-Boley, I. K. Karlsson, G. Leonenko, K. Numbers, E. K. O'Brien, A. Shadrin, A. Thalamuthu, Q. Yang, O. A. Andreassen, H. Brodaty, M. Gatz, N. A. Kochan, J. C. Lambert, S. M. Laws, C. L. Masters, K. A. Mather, N. L. Pedersen, D. Posthuma, P. S. Sachdev, J. Williams, C. C. Fan, S. V. Faraone, C. Fennema-Notestine, S. J. Lin, V. Escott-Price, P.
Published in: Transl Psychiatry, Issue 21583188, 2022, ISSN 2158-3188
Publisher: Nature Publishing Group
DOI: 10.1038/s41398-022-02055-0

Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013–2020)

Author(s): Bruno C, Alys Havard, Malcolm B Gillies, David Coghill, Jonathan Brett, Adam J Guastella, Sallie-Anne Pearson, Helga Zoega
Published in: Australia N Z J Psychiatry, Issue 00048674, 2022, ISSN 0004-8674
Publisher: Blackwell Publishing Inc.
DOI: 10.1177/00048674221114782

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available